Paraquat plaintiffs in the current federal litigation are not receiving finalized per-person payouts yet. Quoted ranges of $20,000 to $1.5 million are attorney projections only, not confirmed MDL payments, according to DrugWatch's settlement review. Paraquat is a powerful weed killer used in farming.
These lawsuits say farmworkers and applicators developed Parkinson's disease after exposure to it. The only public dollar benchmark is an earlier deal. Syngenta agreed on June 1, 2021, to pay $187.5 million to resolve an undisclosed number of early paraquat-Parkinson's claims, as reported by Farm Progress reporting.
Official resources:
- Read the official notice from Uscourts — Use this primary source to verify the official announcement.
- Read the official notice from Drugwatch — Use this primary source to verify the official announcement.
Table of Contents
- The only public settlement number
- Where current lawsuits stand
- Why checks have not gone out
- What would shape a future payment
The only public settlement number
The $187.5 million agreement covers early claims only. It does not set the value for the thousands of cases filed later. Later online averages of $100,000 to $150,000 are also projections.
DrugWatch describes them as attorney estimates, not money paid to MDL plaintiffs. That distinction matters for expectations. A past group deal shows defendants will pay, but it does not promise the same amount per person now.
Where current lawsuits stand
Current federal claims are consolidated as In re Paraquat Products Liability Litigation, MDL No. 3004. The cases sit in the Southern District of Illinois before Chief Judge Nancy J. Rosenstengel.
📨 Get Free Mass Tort Guides Alerts
Free · No spam · Unsubscribe anytime
About 6,602 actions were pending in MDL 3004 as of Oct. 1, 2026, out of 8,495 filed, according to TortAdvisor's docket summary. More than 2,000 related cases are also pending in Philadelphia state court. All these cases are brought by farmworkers and applicators. They allege Parkinson's disease after paraquat exposure against Syngenta and Chevron defendants.
Why checks have not gone out
The parties signed a confidential master settlement agreement in August 2025. They had paused MDL bellwether proceedings in May 2025 to pursue settlement. In 2026, both sides jointly moved to create a Paraquat Products Qualified Settlement Fund under IRC Section 468B.
That type of fund holds future settlement money before allocation. The first Philadelphia bellwether Parkinson's case settled confidentially on Jan. 27-29, 2026, on the eve of trial. No jury verdict set a per-plaintiff value.
What would shape a future payment
Any future payments are expected to be tiered. Key factors include proof of exposure, Parkinson's severity, age, and strength of the individual case. That means two people with Parkinson's could receive different amounts.
Strong work records and a clear diagnosis support a higher tier than weak or mixed proof. Distribution is projected for 2027 and beyond, according to Consumer Notice's lawsuit update. Readers with exposure and a diagnosis can take practical steps now:.
- List farm jobs, years, and paraquat use or spraying nearby
- Save medical records showing Parkinson's diagnosis and treatment
- Keep receipts, employment files, and names of co-workers or applicators
- Ask a mass-tort lawyer to review deadlines for your state
You Might Also Like
- Monsanto Roundup Lawsuit Settlement Update for October 2026
- Hair Relaxer Lawsuit Settlement: Deadlines Plaintiffs Face Before December
- Tylenol Autism Lawsuit: What Plaintiffs Must Show to File a Claim?